Differences in Cardiometabolic Proteins in Pregnancy Prioritize Relevant Targets of Preeclampsia

Kathryn J Lindley1,2, Andrew Perry1, Marni Jacobs3

  • 1Vanderbilt Translational and Clinical Research Center, Cardiovascular Division (K.J.L., A.P., K.A., S.Z., K.T., J.E.F., R.V.S.), Vanderbilt University Medical Center, Nashville, TN.

Insights

Preeclampsia involves vascular inflammation and poses risks to mothers and babies. This study identified novel cardiovascular biomarkers in plasma that could predict preeclampsia and its complications.

Area of Science:

  • Cardiovascular biology
  • Reproductive medicine
  • Proteomics

Background:

  • Preeclampsia is a serious hypertensive disorder of pregnancy with significant maternal and fetal risks.
  • Widespread vascular inflammation characterizes preeclampsia, often occurring without clear risk factors.
  • Predictive biomarkers for preeclampsia and its cardiovascular sequelae are critically needed for prevention.

Purpose of the Study:

  • To investigate differences in cardiovascular proteomic profiles in pregnant individuals with and without preeclampsia.
  • To identify novel plasma biomarkers associated with preeclampsia pathophysiology.

Main Methods:

  • Cardiovascular proteomics analysis using the Olink Explore 384 platform.
  • Study included 256 diverse pregnant individuals across two centers.
  • Comparison of proteomic profiles between individuals delivering with preeclampsia and controls.

Main Results:

  • Significant differences in plasma protein abundance related to angiogenesis, blood pressure, cell adhesion, inflammation, and metabolism were found between preeclampsia cases and controls.
  • Several novel biomarkers not previously described or represented in the placental transcriptome were identified.
  • Early-onset preeclampsia showed distinct dysregulation of proteins involved in hemodynamic stress, hemostasis, and immune response compared to late-onset preeclampsia.

Conclusions:

  • Targeted proteomics effectively identified cardiovascular biomarkers relevant to preeclampsia.
  • These findings underscore the need for larger multiomic studies to develop surveillance and intervention strategies.
  • Identifying biomarkers upstream of diagnosis could enable earlier prevention of adverse pregnancy outcomes.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
92